Project Number ADDF-32 Agency/Funding Organization Alzheimer's Drug Discovery Foundation Funding Year 2021 View Full Project Details for Measurement of immune cell recruitment as a biomarker of neuroinflammation in Alzheimer's disease and other diseases of the central nervous system Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category B. Diagnosis, Assessment, and Disease Monitoring 1. Fluid Biomarkers b. Blood-based Biomarkers Researcher and Organization Principal Investigator Menniti, Frank Principal Investigator Menniti, Frank Awardee Organization MindImmune Therapeutics, Inc. Awardee State Rhode Island Contact PI Country United States Project Detail Funding Opportunity Announcement ADDF-Neuroimaging and CSF Biomarkers Program FY Overall Cost $1,835,000 Funding Organization Agency/Funding Organization Alzheimer's Drug Discovery Foundation Funding Organization Country United States Program Official ADDF Grants Management